The DOI matches its Crossref record; 196 of the 196 references it cites were found in a registry or an index.
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification
Open accessAbstract
Hepatocellular carcinoma (HCC), the primary malignancy of hepatocytes, is a diagnosis with bleak outcome. According to National Cancer Institute’s SEER database, the average five-year survival rate of HCC patients in the US is 19.6% but can be as low as 2.5% for advanced, metastatic disease. When diagnosed at early stages, it is treatable with locoregional treatments including surgical resection, Radio-Frequency Ablation, Trans-Arterial Chemoembolization or liver transplantation. However, HCC is usually diagnosed at advanced stages when the tumor is unresectable, making these treatments ineffective. In such instances, systemic therapy with tyrosine kinase inhibitors (TKIs) becomes the only viable option, even though it benefits only 30% of patients, provides only a modest (~3 months) increase in overall survival and causes drug resistance within 6 months. HCC, like many other cancers, is highly heterogeneous making a one-size fits all option problematic. The selection of liver transplantation, locoregional treatment, TKIs or immune checkpoint inhibitors as a treatment strategy depends on the disease stage and underlying condition(s). Additionally, patients with similar disease phenotype can have different molecular etiology making treatment responses different. Stratification of patients at the molecular level would facilitate development of the most effective treatment option. With the increase in efficiency and affordability of “omics”-level analysis, considerable effort has been expended in classifying HCC at the molecular, metabolic and immunologic levels. This review examines the results of these efforts and the ways they can be leveraged to develop targeted treatment options for HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kannan, M., Jayamohan, S., Moorthy, R., Chabattula, S. C., Ganeshan, M., & Arockiam, A. J. V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225526 · Cited by 20
RetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941 · cited 1×
“It was modified in 1973 to substitute the variable clinical nutritional status with prothrombin time (Pugh et al., 1973).”
MethodHepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
Llovet, J., Brú, C., & Bruix, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007122 · Cited by 3,805
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016) · Metabolism · doi:10.1016/j.metabol.2015.12.012 · Cited by 3,119
Malinchoc, M., Kamath, P. S., Gordon, F. D., Peine, C. J., Rank, J., & ter Borg, P. C. J. (2000) · Hepatology · doi:10.1053/he.2000.5852 · Cited by 2,893
Johnson, P. J., Berhane, S., Kagebayashi, C., Satomura, S., Teng, M., Reeves, H. L., O'Beirne, J., Fox, R., Skowronska, A., Palmer, D., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.9151 · Cited by 2,783
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Ally, A., Balasundaram, M., Carlsen, R., Chuah, E., Clarke, A., Dhalla, N., Holt, R. A., Jones, S. J. M., Lee, D., Ma, Y., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.046 · Cited by 2,490
Estes, C., Razavi, H., Loomba, R., Younossi, Z., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,399
Non-alcoholic fatty liver disease - a global public health perspective
Younossi, Z. M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.033 · Cited by 2,149
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963
Surgery and portal hypertension.
Child, C. G., & Turcotte, J. (1964) · PubMed · Cited by 1,933
Epidemiology and Management of Hepatocellular Carcinoma
Kulik, L., & El-Serag, H. B. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.08.065 · Cited by 1,735
Immune evasion in cancer: mechanistic basis and therapeutic strategies
Vinay, D. S., Ryan, E. P., Pawelec, G., Talib, W. H., Stagg, J., Elkord, E., Lichtor, T., Decker, W. K., Whelan, R. L., Kumara, H. M. C. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.004 · Cited by 1,625
Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Maad, I. B., Calderaro, J., Bioulac-Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,453
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Kota, J., Chivukula, R. R., O'Donnell, K. A., Wentzel, E. A., Montgomery, C. L., Hwang, H.-W., Chang, T.-C., Vivekanandan, P., Torbenson, M., Clark, K. R., et al. (2009) · Cell · doi:10.1016/j.cell.2009.04.021 · Cited by 1,452
Ascha, M. S., Hanouneh, I. A., Lopez, R., Tamimi, T. A.-R., Feldstein, A. F., & Zein, N. N. (2010) · Hepatology · doi:10.1002/hep.23527 · Cited by 1,296
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Boyault, S., Rickman, D. S., de Reyniès, A., Balabaud, C., Rebouissou, S., Jeannot, E., Hérault, A., Saric, J., Belghiti, J., Franco, D., et al. (2007) · Hepatology · doi:10.1002/hep.21467 · Cited by 1,258
Hoshida, Y., Nijman, S. M. B., Kobayashi, M., Chan, J. A., Brunet, J.-P., Chiang, D. Y., Villanueva, A., Newell, P., Ikeda, K., Hashimoto, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1089 · Cited by 1,238 · cited 5×
“Immune-high group was associated with Hoshida’s S1 and Boyault’s G2 and Immune-low subtype with Hoshida’s S3 and Boyault’s G6 subclasses (Boyault et al., 2007; Hoshida et al., 2009).”
BackgroundMethodInfluentialA new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
(1998) · Hepatology · doi:10.1002/hep.510280322 · Cited by 1,238
Hepatitis B: The virus and disease #
Liang, J. T. (2009) · Hepatology · doi:10.1002/hep.22881 · Cited by 1,061
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma
Sung, W.-K., Zheng, H., Li, S., Chen, R., Liu, X., Li, Y., Lee, N. P., Lee, W. H., Ariyaratne, P. N., Tennakoon, C., et al. (2012) · Nature Genetics · doi:10.1038/ng.2295 · Cited by 991
Fujimoto, A., Totoki, Y., Abe, T., Boroevich, K. A., Hosoda, F., Nguyen, H. H., Aoki, M., Hosono, N., Kubo, M., Miya, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2291 · Cited by 870
Petruzziello, A., Marigliano, S., Loquercio, G., Cozzolino, A., & Cacciapuoti, C. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i34.7824 · Cited by 864
Aflatoxins: A Global Concern for Food Safety, Human Health and Their Management
Kumar, P., Mahato, D. K., Kamle, M., Mohanta, T. K., & Kang, S. G. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02170 · Cited by 843
Evidence-Based Incorporation of Serum Sodium Concentration Into MELD
Biggins, S. W., Kim, W. R., Terrault, N. A., Saab, S., Balan, V., Schiano, T., Benson, J., Therneau, T., Kremers, W., Wiesner, R., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.010 · Cited by 790
Calderaro, J., Couchy, G., Imbeaud, S., Amaddeo, G., Letouzé, E., Blanc, J.-F., Laurent, C., Hajji, Y., Azoulay, D., Bioulac-Sage, P., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.014 · Cited by 780
Trevisani, F., D'Intino, P. E., Morselli-Labate, A. M., Mazzella, G., Accogli, E., Caraceni, P., Domenicali, M., De Notariis, S., Roda, E., & Bernardi, M. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00053-2 · Cited by 731
The new liver allocation system: Moving toward evidence-based transplantation policy
Freeman, R. B., Wiesner, R. H., Harper, A., McDiarmid, S. V., Lake, J., Edwards, E., Merion, R., Wolfe, R., Turcotte, J., & Teperman, L. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.35927 · Cited by 724
Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma
Chiang, D. Y., Villanueva, A., Hoshida, Y., Peix, J., Newell, P., Minguez, B., LeBlanc, A. C., Donovan, D. J., Thung, S. N., Solé, M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0742 · Cited by 719
EpCAM and α-Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma
Yamashita, T., Forgues, M., Wang, W., Kim, J. W., Ye, Q., Jia, H., Budhu, A., Zanetti, K. A., Chen, Y., Qin, L.-X., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6013 · Cited by 717
Wang, X. W., Forrester, K., Yeh, H., Feitelson, M. A., Gu, J. R., & Harris, C. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2230 · Cited by 665
The development of cirrhosis in patients with chronic type B hepatitis: A prospective study
Liaw, Y.-F., Tai, D.-I., Chu, C.-M., & Chen, T.-J. (1988) · Hepatology · doi:10.1002/hep.1840080310 · Cited by 612
Su, H., Yang, J.-R., Xu, T., Huang, J., Xu, L., Yuan, Y., & Zhuang, S.-M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2886 · Cited by 612
Risk of Cirrhosis and Primary Liver Cancer in Alpha1-Antitrypsin Deficiency
Eriksson, S., Carlson, J., & Velez, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603203141202 · Cited by 580
Donato, F., Boffetta, P., & Puoti, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980130)75:3<347::aid-ijc4>3.0.co;2-2 · Cited by 543
Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence
Rehermann, B. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39133 · Cited by 531
Risks of chronicity following acute hepatitis B virus infection: a review.
Hyams, K. C. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.4.992 · Cited by 521
Aguilar, F., Hussain, S. P., & Cerutti, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8586 · Cited by 489
Natural History and Life Expectancy in Severe Alpha1‐Antitrypsin Deficiency, Pi Z
Larsson, C. (1978) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1978.tb08452.x · Cited by 484
Pierantonelli, I., & Svegliati-Baroni, G. (2019) · Transplantation · doi:10.1097/tp.0000000000002480 · Cited by 460
Kurebayashi, Y., Ojima, H., Tsujikawa, H., Kubota, N., Maehara, J., Abe, Y., Kitago, M., Shinoda, M., Kitagawa, Y., & Sakamoto, M. (2018) · Hepatology · doi:10.1002/hep.29904 · Cited by 454
HBV DNA Integration: Molecular Mechanisms and Clinical Implications
Tu, T., Budzinska, M., Shackel, N., & Urban, S. (2017) · Viruses · doi:10.3390/v9040075 · Cited by 447
Liver fibrosis: Direct antifibrotic agents and targeted therapies
Schuppan, D., Ashfaq-Khan, M., Yang, A. T., & Kim, Y. O. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.04.006 · Cited by 435
Takano, S., Yokosuka, O., Imazeki, F., Tagawa, M., & Omata, M. (1995) · Hepatology · doi:10.1002/hep.1840210308 · Cited by 432
Wong, Q. W. –., Lung, R. W. –., Law, P. T. –., Lai, P. B. –., Chan, K. Y. –., To, K., & Wong, N. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.003 · Cited by 424
PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or Inhibition
Wu, Y., Chen, W., Xu, Z. P., & Gu, W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02022 · Cited by 419
Benn, J., & Schneider, R. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10350 · Cited by 418
STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?
Asselah, T., Rubbia-Brandt, L., Marcellin, P., & Negro, F. (2006) · Gut · doi:10.1136/gut.2005.069757 · Cited by 395
Iron, hemochromatosis, and hepatocellular carcinoma
Kowdley, K. V. (2004) · Gastroenterology · doi:10.1016/j.gastro.2004.09.019 · Cited by 391
Agren, R., Mardinoglu, A., Asplund, A., Kampf, C., Uhlen, M., & Nielsen, J. (2014) · Molecular Systems Biology · doi:10.1002/msb.145122 · Cited by 387
DNA adducts from acetaldehyde: implications for alcohol-related carcinogenesis
Brooks, P. J., & Theruvathu, J. A. (2005) · Alcohol · doi:10.1016/j.alcohol.2005.03.009 · Cited by 382
Alcoholic liver disease and the gut-liver axis
Szabo, G. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i11.1321 · Cited by 378
Functional inactivation but not structural mutation of p53 causes liver cancer
Ueda, H., Ullrich, S. J., Gangemi, J. D., Kappel, C. A., Ngo, L., Feitelson, M. A., & Jay, G. (1995) · Nature Genetics · doi:10.1038/ng0195-41 · Cited by 367
Acetaldehyde adducts in alcoholic liver disease
Setshedi, M., Wands, J. R., & de la Monte, S. M. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.3.12288 · Cited by 365
Manns, M. P., Johnson, E. F., Griffin, K. J., Tan, E. M., & Sullivan, K. F. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113949 · Cited by 363
Wang, Y., Lee, A. T. C., Ma, J. Z. I., Wang, J., Ren, J., Yang, Y., Tantoso, E., Li, K.-B., Ooi, L. L. P. J., Tan, P., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707629200 · Cited by 363
Hepatocellular carcinoma in the setting of alcohol-related liver disease
Ganne-Carrié, N., & Nahon, P. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.008 · Cited by 360
Non-alcoholic fatty liver disease
Maurice, J., & Manousou, P. (2018) · Clinical Medicine · doi:10.7861/clinmedicine.18-3-245 · Cited by 357
Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
Zhao, L.-H., Liu, X., Yan, H.-X., Li, W.-Y., Zeng, X., Yang, Y., Zhao, J., Liu, S.-P., Zhuang, X.-H., Lin, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms12992 · Cited by 344
HAMID, A. S., TESFAMARIAM, I. G., ZHANG, Y., & ZHANG, Z. G. (2013) · Oncology Letters · doi:10.3892/ol.2013.1169 · Cited by 339
The Phenotypes of Pluripotent Human Hepatic Progenitors
Schmelzer, E., Wauthier, E., & Reid, L. M. (2006) · STEM CELLS · doi:10.1634/stemcells.2006-0036 · Cited by 333
Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis
Elmore, L. W., Hancock, A. R., Chang, S.-F., Wang, X. W., Chang, S., Callahan, C. P., Geller, D. A., Will, H., & Harris, C. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14707 · Cited by 333
Kim, J. K., Noh, J. H., Jung, K. H., Eun, J. W., Bae, H. J., Kim, M. G., Chang, Y. G., Shen, Q., Park, W. S., Lee, J. Y., et al. (2013) · Hepatology · doi:10.1002/hep.26101 · Cited by 326
Zhang, Q., Lou, Y., Yang, J., Wang, J., Feng, J., Zhao, Y., Wang, L., Huang, X., Fu, Q., Ye, M., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318912 · Cited by 326
Fibrosis and alcohol-related liver disease
Lackner, C., & Tiniakos, D. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.003 · Cited by 322
Abrogation of p53-Induced Apoptosis by the Hepatitis B Virus X Gene
Wang, X. W. (2003) · Hepatocellular Carcinoma · doi:10.1385/1-59259-079-9:57 · Cited by 321
Glycogen Storage Disease Type III diagnosis and management guidelines
Kishnani, P. S., Austin, S. L., Arn, P., Bali, D. S., Boney, A., Case, L. E., Chung, W. K., Desai, D. M., El-Gharbawy, A., Haller, R., et al. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181e655b6 · Cited by 311
Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis
Kew, M. C. (2003) · Liver International · doi:10.1111/j.1478-3231.2003.00869.x · Cited by 302
Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor α
Su, F., & Schneider, R. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8744 · Cited by 300
Mechanisms of hepatocellular carcinoma progression
Ogunwobi, O. O., Harricharran, T., Huaman, J., Galuza, A., Odumuwagun, O., Tan, Y., Ma, G. X., & Nguyen, M. T. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i19.2279 · Cited by 291
Wu, Y., Whitman, I., Molmenti, E., Moore, K., Hippenmeyer, P., & Perlmutter, D. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9014 · Cited by 290
Glycogen storage diseases: New perspectives
Özen, H. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i18.2541 · Cited by 287
Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives
Elmberg, M., Hultcrantz, R., Ekbom, A., Brandt, L., Olsson, S., Olsson, R., Lindgren, S., Lööf, L., Stål, P., Wallerstedt, S., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.035 · Cited by 273 · cited 1×
“Incidence of cirrhosis in HH patients is 10–25% and HCC incidence in HH patients is 8–10% (Kew, 2014) and the increase in risk for HCC development has been reported to be ~20-fold compared to healthy individuals (Elmberg et al., 2003).”
BackgroundHepatic Metastasis from Colorectal Cancer
Valderrama-Treviño, A. I., Barrera-Mera, B., Ceballos-Villalva, J. C., & Montalvo-Javé, E. E. (2017) · Euroasian Journal of Hepato-Gastroenterology · doi:10.5005/jp-journals-10018-1241 · Cited by 257
miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines
Lin, C. J.-F., Gong, H.-Y., Tseng, H.-C., Wang, W.-L., & Wu, J.-L. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.154 · Cited by 256
Wong, Q. W.-L., Ching, A. K.-K., Chan, A. W.-H., Choy, K.-W., To, K.-F., Lai, P. B.-S., & Wong, N. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1840 · Cited by 248
Fracanzani, A. (2001) · Hepatology · doi:10.1053/jhep.2001.22506 · Cited by 245
New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA
Zoulim, F. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.12.015 · Cited by 244
Bukh, J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.035 · Cited by 244
Hepatic Iron Overload and Hepatocellular Carcinoma
Kew, M. C. (2014) · Liver Cancer · doi:10.1159/000343856 · Cited by 239
Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.
Zanger, U. M., Hauri, H. P., Loeper, J., Homberg, J. C., & Meyer, U. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.8256 · Cited by 238
Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver
de Boer, C. J., van Krieken, J. H. J. M., Janssen-van Rhijn, C. M., & Litvinov, S. V. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199906)188:2<201::aid-path339>3.0.co;2-8 · Cited by 236
Su, F., & Schneider, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4558-4566.1996 · Cited by 229
Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies
Turati, F., Galeone, C., Rota, M., Pelucchi, C., Negri, E., Bagnardi, V., Corrao, G., Boffetta, P., & La Vecchia, C. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu020 · Cited by 229
Cha, M.-Y., Kim, C.-M., Park, Y.-M., & Ryu, W.-S. (2004) · Hepatology · doi:10.1002/hep.20245 · Cited by 220
Bidkhori, G., Benfeitas, R., Klevstig, M., Zhang, C., Nielsen, J., Uhlen, M., Boren, J., & Mardinoglu, A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807305115 · Cited by 211
Ding, D., Lou, X., Hua, D., Yu, W., Li, L., Wang, J., Gao, F., Zhao, N., Ren, G., Li, L., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003065 · Cited by 209
Roy, C. N., Penny, D. M., Feder, J. N., & Enns, C. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.9022 · Cited by 206
Mitochondrial autophagy and injury in the liver in α1-antitrypsin deficiency
Teckman, J. H., An, J.-K., Blomenkamp, K., Schmidt, B., & Perlmutter, D. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00175.2003 · Cited by 202
An overview of HCV molecular biology, replication and immune responses
Ashfaq, U. A., Javed, T., Rehman, S., Nawaz, Z., & Riazuddin, S. (2011) · Virology Journal · doi:10.1186/1743-422x-8-161 · Cited by 200
(1985) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/75.1.81 · Cited by 195
Lin, X., Li, A.-M., Li, Y.-H., Luo, R.-C., Zou, Y.-J., Liu, Y.-Y., Liu, C., Xie, Y.-Y., Zuo, S., Liu, Z., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0111-4 · Cited by 191
Metabolism‐associated molecular classification of hepatocellular carcinoma
Yang, C., Huang, X., Liu, Z., Qin, W., & Wang, C. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12639 · Cited by 189
Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia‐inducible factor‐1α
Moon, E., Jeong, C., Jeong, J., Rok Kim, K., Yu, D., Murakami, S., Woo Kim, C., & Kim, K. (2004) · The FASEB Journal · doi:10.1096/fj.03-0153fje · Cited by 187
Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis
Tarocchi, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i33.11630 · Cited by 186
Alcohol-induced steatosis in liver cells
Jr, T. M. D. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i37.4974 · Cited by 186
Lee, Y. I., Kang-Park, S., Do, S.-I., & Lee, Y. I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011263200 · Cited by 185
Glycogen storage disease I and hepatocellular tumours
Bianchi, L. (1993) · European Journal of Pediatrics · doi:10.1007/bf02072092 · Cited by 183
Surgical considerations in hypertension
William Scott, H., & Foster, J. H. (1964) · Current Problems in Surgery · doi:10.1016/s0011-3840(64)80003-4 · Cited by 180
Kim, M., Lee, H. C., Tsedensodnom, O., Hartley, R., Lim, Y.-S., Yu, E., Merle, P., & Wands, J. R. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.12.020 · Cited by 179
XU, Y., AN, Y., WANG, Y., ZHANG, C., ZHANG, H., HUANG, C., JIANG, H., WANG, X., & LI, X. (2013) · Oncology Reports · doi:10.3892/or.2013.2338 · Cited by 169
Hepatitis C virus: virology and life cycle
Kim, C. W., & Chang, K.-M. (2013) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2013.19.1.17 · Cited by 168
Sucher, E., Sucher, R., Gradistanac, T., Brandacher, G., Schneeberger, S., & Berg, T. (2019) · Journal of Immunology Research · doi:10.1155/2019/9437043 · Cited by 168
Xu, L., Beckebaum, S., Iacob, S., Wu, G., Kaiser, G. M., Radtke, A., Liu, C., Kabar, I., Schmidt, H. H., Zhang, X., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.10.028 · Cited by 162
Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities
De Matteis, S., Ragusa, A., Marisi, G., De Domenico, S., Casadei Gardini, A., Bonafè, M., & Giudetti, A. M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7512159 · Cited by 160
Porphyria Diagnostics—Part 1: A Brief Overview of the Porphyrias
Ramanujam, V. S., & Anderson, K. E. (2015) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1720s86 · Cited by 158
Pathogenesis of autoimmune hepatitis
Liberal, R., Longhi, M. S., Mieli‐Vergani, G., & Vergani, D. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.09.009 · Cited by 157
Cross, J. C., Wen, P., & Rutter, W. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8078 · Cited by 156
Immune Response in Hepatitis B Virus Infection
Tan, A. T., Koh, S., & Bertoletti, A. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021428 · Cited by 156
Liver injury in α1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury
Perlmutter, D. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16787 · Cited by 154
Andant, C., Puy, H., Bogard, C., Faivre, J., Soulé, J.-C., NORDMANN, Y., & Deybach, J. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80097-5 · Cited by 148
Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?
Demo, E. M., Frush, D. P., Gottfried, M. R., Koepke, J. A., Boney, A., Bali, D. S., Chen, Y.-T., & Kishnani, P. S. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.09.022 · Cited by 145
Forgues, M., Difilippantonio, M. J., Linke, S. P., Ried, T., Nagashima, K., Feden, J. P., Valerie, K. C., Fukasawa, K., & Wang, X. W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.15.5282-5292.2003 · Cited by 145
Aflatoxins: Implications on Health
Sarma, U. P., Bhetariya, P. J., Devi, P., & Varma, A. (2017) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-017-0649-2 · Cited by 142
Cancer-associated molecular signature in the tissue samples of patients with cirrhosis†
Kim, J. W., Ye, Q., Forgues, M., Chen, Y., Budhu, A., Sime, J., Hofseth, L. J., Kaul, R., & Wang, X. W. (2004) · Hepatology · doi:10.1002/hep.20053 · Cited by 141
Pietrangelo, A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.05.013 · Cited by 140
Tsang, F. H., Au, S. L., Wei, L., Fan, D. N.-Y., Lee, J. M. F., Wong, C. C., Wong, C. C., Ng, I. O., Wong, C., & Wong, C. (2014) · Liver International · doi:10.1111/liv.12746 · Cited by 137
Hsieh, A., Kim, H.-S., Lim, S., Yu, D., & Jung, G. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.09.018 · Cited by 136
Liver injury in α1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury
Perlmutter, D. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216787 · Cited by 133
Saigo, K., Yoshida, K., Ikeda, R., Sakamoto, Y., Murakami, Y., Urashima, T., Asano, T., Kenmochi, T., & Inoue, I. (2008) · Human Mutation · doi:10.1002/humu.20701 · Cited by 128
MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells
Yang, T., Zheng, Z., Li, X., Li, Z.-F., Wang, Y., Geng, Y.-F., Li, B., & Zhang, X. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213497321 · Cited by 121
Hepatic injury in chronic iron overload. Role of lipid peroxidation
Bacon, B. R., & Britton, R. S. (1989) · Chemico-Biological Interactions · doi:10.1016/0009-2797(89)90045-8 · Cited by 117
The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria
Andersson, C., Bjersing, L., & Lithner, F. (1996) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1996.21847000.x · Cited by 114
Polyploidy spectrum: a new marker in HCC classification
Bou-Nader, M., Caruso, S., Donné, R., Celton‐Morizur, S., Caldéraro, J., Gentric, G., Cadoux, M., L’Hermitte, A., Klein, C., Guilbert, T., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-318021 · Cited by 113
Jin, Y., Wang, J., Han, J., Luo, D., & Sun, Z. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.09.010 · Cited by 111
Li, R. F. (2011) · Oncology Reports · doi:10.3892/or.2011.1375 · Cited by 109
Zhou, Y., Chen, E., Tang, Y., Mao, J., Shen, J., Zheng, X., Xie, S., Zhang, S., Wu, Y., Liu, H., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2053-8 · Cited by 109
Lee, S., Lee, Y. M., Bae, S., Murakami, S., Yun, Y., & Kim, K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2093 · Cited by 106
Pathogenesis of Chronic Liver Injury and Hepatocellular Carcinoma in Alpha-1-Antitrypsin Deficiency
Perlmutter, D. H. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000228350.61496.90 · Cited by 103
Elzouki, A.-N., & Eriksson, S. (1996) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199610000-00010 · Cited by 102
MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer
Noh, J. H., Chang, Y. G., Kim, M. G., Jung, K. H., Kim, J. K., Bae, H. J., Eun, J. W., Shen, Q., Kim, S.-J., Kwon, S. H., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.003 · Cited by 102
Hepatic glycogen storage disorders
Burda, P., & Hochuli, M. (2015) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000181 · Cited by 101
Chan, A. C. Y., Fan, S. T., Poon, R. T. P., et al. (2012) · HPB · doi:10.1111/j.1477-2574.2012.00617.x · Cited by 101
Porphyria Cutanea Tarda and Hepatocellular Carcinoma
Salata, H., Cortés, J. M. S., de Salamanca, R. E., Oliva, H., Castro, A., Kusak, E., Carréño, V., & Guio, C. H. (1985) · Journal of Hepatology · doi:10.1016/s0168-8278(85)80746-7 · Cited by 96
Sartorius, K., Makarova, J. A., Sartorius, B. K. D., An, P., Winkler, C. A., Chuturgoon, A. A., & Kramvis, A. (2019) · Cells · doi:10.3390/cells8121504 · Cited by 95
Survival and Causes of Death in Hemochromatosis
Strohmeyer, G. W., Niederau, C., & Stremmel, W. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb55510.x · Cited by 90
Shiraishi, Y., Fujimoto, A., Furuta, M., Tanaka, H., Chiba, K., Boroevich, K. A., Abe, T., Kawakami, Y., Ueno, M., Gotoh, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114263 · Cited by 90
MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling
Wang, Y., Chen, H., Cheng, J., Chen, B., Ke, Q., Lv, Z., Wu, J., & Zhou, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.03.107 · Cited by 89
Yun, C., Cho, H., Kim, S.-J., Lee, J., Park, S. Y., Chan, G. K. T., & Cho, H. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.159.2.3 · Cited by 89
Hua, S., Quan, Y., Zhan, M., Liao, H., Li, Y., & Lu, L. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0919-6 · Cited by 89
Sze, K. M., Ho, D. W., Chiu, Y., Tsui, Y., Chan, L., Lee, J. M., Chok, K., Chan, A. C. Y., Tang, C. N., Tang, V. W., et al. (2020) · Hepatology · doi:10.1002/hep.31231 · Cited by 86
Fujii, R., Zhu, C., Wen, Y., Marusawa, H., Bailly‐Maitre, B., Matsuzawa, S.-I., Zhang, H., Kim, Y. S., Bennett, C. F., Jiang, W. B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1886 · Cited by 85
miR-224 functions as an onco-miRNA in hepatocellular carcinoma cells by activating AKT signaling
Ma, D., TAO, X., Gao, F., Fan, C., & Wu, D. (2012) · Oncology Letters · doi:10.3892/ol.2012.742 · Cited by 82
Hepatitis B Virus Promotes Angiopoietin-2 Expression in Liver Tissue
Sanz-Cameno, P., Martín‐Vílchez, S., Lara‐Pezzi, E., Borque, M. J., Salmerón, J., de Rueda, P. M., Solís, J. A., López‐Cabrera, M., & Moreno‐Otero, R. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051246 · Cited by 81
MicroRNA‐224 is upregulated in HepG2 cells and involved in cellular migration and invasion
Li, Q., Wang, G., Shan, J., Yang, Z., Wang, H., Feng, J., Zhen, J., Chen, C., Zhang, Z., Xu, W., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05971.x · Cited by 81
Cho, S., & Kakar, S. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2018-0082-ra · Cited by 80
Wen, Y., Golubkov, V. S., Strongin, A. Y., Jiang, W. B., & Reed, J. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708419200 · Cited by 78
Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology
Hiraoka, N. (2010) · International Journal of Clinical Oncology · doi:10.1007/s10147-010-0130-1 · Cited by 78
Li, C., Li, C., Lin, Y., Ho, M., Chen, D., Chen, P., & Yeh, S. (2018) · Hepatology · doi:10.1002/hep.30201 · Cited by 75
Cell cycle regulators and human hepatocarcinogenesis.
Hui, A., Makuuchi, M., & Li, X. (1999) · PubMed · Cited by 74
Lee, S., Tarn, C., Wang, W., Chen, S., Hullinger, R. L., & ANDRISANI, O. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108025200 · Cited by 73
Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers
Furuta, M., Tanaka, H., Shiraishi, Y., Uchida, T., Imamura, M., Fujimoto, A., Fujita, M., Sasaki-Oku, A., Maejima, K., Nakano, K., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25308 · Cited by 73
Xu, J., An, P., Winkler, C. A., & Yu, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01271 · Cited by 72
Agarwal, R., Narayan, J., Bhattacharyya, A., Saraswat, M., & Tomar, A. K. (2017) · Cancer Genetics · doi:10.1016/j.cancergen.2017.06.002 · Cited by 71
Glycogen Storage Disease Type Ia and VI Associated With Hepatocellular Carcinoma: Two Case Reports
Manzia, T. M., Angelico, R., Toti, L., Cillis, A., Ciano, P., Orlando, G., Anselmo, A., Angelico, M., & Tisone, G. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.01.129 · Cited by 68
Kuo, T.-C., & Chao, C. C. ‐. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.003 · Cited by 68
The multiple facets of alpha-1-antitrypsin.
Stockley, R. A. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.04.25 · Cited by 67
miR-21 promotes cell migration and invasion of hepatocellular carcinoma by targeting KLF5
Wang, J., Chu, Y., Xu, M., Zhang, X., Zhou, Y., & Xu, M. (2018) · Oncology Letters · doi:10.3892/ol.2018.9843 · Cited by 67
HBV X protein targets hBubR1, which induces dysregulation of the mitotic checkpoint
Kim, S., Park, S. Y., Yong, H., Famulski, J. K., Chae, S., Lee, J.-H., Kang, C.-M., Saya, H., Chan, G. K. T., & Cho, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210998 · Cited by 65
Hu, L., Chen, L., Yang, G.-Z., Liang, L., Sun, H., Chang, Y., Tu, Q., Wu, M., & Wang, H. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-43 · Cited by 65
MiR-199a Regulates Cell Proliferation and Survival by Targeting FZD7
Song, J., Gao, L., Yang, G., Tang, S., Xie, H., Wang, Y., Wang, J., Zhang, Y., Jin, J., Gou, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110074 · Cited by 63
Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma
Yu, J. H., Lee, W. Y., Toh, S. T., Tennakoon, C., Toh, H. C., Chow, P. K. H., Chung, A. Y. F., Chong, S. S., Ooi, L. L., Sung, W.-K. K., et al. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2025-x · Cited by 62
Bergeron, A., D’Astous, M., Timm, D. E., & Tanguay, R. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009341200 · Cited by 52
Mysteries of α1-antitrypsin deficiency: emerging therapeutic strategies for a challenging disease
Ghouse, R., Chu, A. S., Wang, Y., & Perlmutter, D. H. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.014092 · Cited by 51
Neto, J. S., Leite, K. R. M., Porta, A., da Fonseca, E. A., Feier, F. H., Pugliese, R. P. S., Miura, I. K., Chapchap, P., & Porta, G. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25094 · Cited by 49
Liver Cancer in Tyrosinemia Type 1
van Ginkel, W. G., Pennings, J. P., & van Spronsen, F. J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55780-9_9 · Cited by 48
MiR-125b attenuates human hepatocellular carcinoma malignancy through targeting SIRT6.
Shi, S., Yang, Y., Liu, M., Liu, B., Yang, X. P., Yu, M., Qi, H., Ren, M., Wang, Z., Zou, J., et al. (2018) · Europe PMC (PubMed Central) · Cited by 48
Yang, X., Wang, J., Qu, S., Zhang, H., Ruan, B., Gao, Y., Ma, B., Wang, X., Wu, N., Li, X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3486 · Cited by 43
Cao, K., Li, J., Zhao, Y., Wang, Q., Zeng, Q., He, S., Li, Y., Zhou, J., & Cao, P. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.2161 · Cited by 43
The transition from inflammation to cancer in the liver
Villanueva, A., & Luedde, T. (2016) · Clinical Liver Disease · doi:10.1002/cld.578 · Cited by 43
Aflatoxins as a risk factor for liver cirrhosis: a systematic review and meta-analysis
Mekuria, A. N., Routledge, M. N., Gong, Y. Y., & Sisay, M. (2020) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-020-00420-7 · Cited by 43
MiR-221 Promotes Hepatocellular Carcinoma Cells Migration via Targeting PHF2
Fu, Y., Liu, M., Li, F., Li, Q., Zhang, P., Lv, F., Cheng, W., & Hou, R. (2019) · BioMed Research International · doi:10.1155/2019/4371405 · Cited by 42
Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and Pathogen
Lumley, S., McNaughton, A. L., Klenerman, P., Lythgoe, K., & Matthews, P. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01561 · Cited by 41
Haemochromatosis: a clinical update for the practising physician
Radford‐Smith, D. E., Powell, E. E., & Powell, L. W. (2018) · Internal Medicine Journal · doi:10.1111/imj.13784 · Cited by 40
Zhao, W., Lin, X., Liu, Y., Han, L.-X., Li, J., Lin, T., Shi, J., Wang, S., Lian, M., Chen, H., et al. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0270-5 · Cited by 40
Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma
Plissonnier, M., Herzog, K., Levrero, M., & Zeisel, M. B. (2018) · Viruses · doi:10.3390/v10110591 · Cited by 39
MicroRNA-200a inhibits cell growth and metastasis by targeting Foxa2 in hepatocellular carcinoma
Chen, S., Ma, D.-N., Chen, Q.-D., Zhang, J., Tian, Y., Wang, Z., Cai, H., Lin, Y., & Sun, H. (2017) · Journal of Cancer · doi:10.7150/jca.17394 · Cited by 35
Jin, Y., Wu, D., Yang, W., Weng, M., Li, Y., Wang, X., Zhang, X. L., Jin, X., & Wang, T. (2017) · Virology Journal · doi:10.1186/s12985-017-0903-5 · Cited by 35
Baravelli, C. M., Sandberg, S., Aarsand, A. K., & Tollånes, M. C. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1051-3 · Cited by 35
Ep-CAM in malignant liver tumours
Ruck, P., von Wichert, G., Handgretinger, R., & KAISERLING, E. (2000) · The Journal of Pathology · Cited by 33
The risk of liver cancer in autoimmune liver diseases
Lleò, A., de Boer, Y. S., Liberal, R., & Colombo, M. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919861914 · Cited by 33
Liu, Z., Wang, C., Jiao, X., Zhao, S., Liu, X., Wang, Y., & Zhang, J. (2016) · PubMed Central · Cited by 32
Innate immunity and cancer therapy
Maruyama, K., Selmani, Z., Ishii, H., & Yamaguchi, K. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.09.012 · Cited by 30
A classification based on tumor budding and immune score for patients with hepatocellular carcinoma
Li, W., Delin, Z., Kefei, Y., Wu, H. M., Jiwei, H., & Zhang, Y. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1672495 · Cited by 29
Wang, X., Lu, J., Cao, J., Ma, B., Gao, C., & Qi, F. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s180971 · Cited by 28
Valean, S. D., Acalovschi, M., Dumitrascu, D. L., Ciobanu, L., Nagy, G. A., & Chira, R. I. (2019) · Medicine and Pharmacy Reports · doi:10.15386/mpr-1228 · Cited by 28
Identification of genes involved in the regulation of TERT in hepatocellular carcinoma
Amisaki, M., Tsuchiya, H., Sakabe, T., Fujiwara, Y., & Shiota, G. (2018) · Cancer Science · doi:10.1111/cas.13884 · Cited by 24
The Hepatitis B Virus Pre-Core Protein p22 Activates Wnt Signaling
Tran, B. M., Flanagan, D. J., Ebert, G., Warner, N., Tran, H., Fifis, T., Kastrappis, G., Christophi, C., Pellegrini, M., Torresi, J., et al. (2020) · Cancers · doi:10.3390/cancers12061435 · Cited by 23
Molecular Pathogenesis of Liver Injury in Hereditary Tyrosinemia 1
Tanguay, R. M., Angileri, F., & Vogel, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55780-9_4 · Cited by 22
Cho, J., Lee, Y. M., Bae, S., & CHOU, J. Y. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.061 · Cited by 19
von Olshausen, G., Quasdorff, M., Bester, R., Arzberger, S., Ko, C., van de Klundert, M. A. A., Zhang, K., Odenthal, M., Ringelhan, M., Niessen, C. M., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26103 · Cited by 17
PD-1 expression and its significance in tumour microenvironment of hepatocellular carcinoma
Tan, K. W., Chacko, A., & Chew, V. (2019) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.06.08 · Cited by 17
The transcriptomic G1–G6 signature of hepatocellular carcinoma in an Asian population
Allen, J. C., Nault, J., Zhu, G., Khor, A. Y. K., Liu, J., Lim, T. K. H., Zucman‐Rossi, J., & Chow, P. K. H. (2016) · Medicine · doi:10.1097/md.0000000000005263 · Cited by 9
Cited by
Predictors of early and late hepatocellular carcinoma recurrence
Nevola, R., Ruocco, R., Criscuolo, L., Villani, A., Alfano, M., Beccia, D., Imbriani, S., Claar, E., Cozzolino, D., Sasso, F. C., et al. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i8.1243 · Cited by 274
Sharma, N., Singh, L., Sharma, A., Kumar, A., & Mahajan, D. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107375 · Cited by 16
Sittiju, P., Wudtiwai, B., Chongchai, A., Hajitou, A., Kongtawelert, P., Pothacharoen, P., & Suwan, K. (2024) · Nanoscale · doi:10.1039/d3nr05660k · Cited by 12
Metadata
- Venue
- Advances in Cancer Research
- Publisher
- Elsevier
- Published
- 2021
- Volume
- 149
- Pages
- 1-61
- ISSN
- 0065-230X (ISSN-L)
- OpenAlex
- W3107895035
- Cited by
- 851
- References
- 196
- FWCI
- 215.74
- Type
- book chapter
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.